Nutex Health (NASDAQ:NUTX) Cut to Buy at Wall Street Zen

Wall Street Zen cut shares of Nutex Health (NASDAQ:NUTX) from a strong-buy rating to a buy rating in a report issued on Monday.

NUTX has been the subject of a number of other research reports. Zacks Research raised shares of Nutex Health to a “hold” rating in a report on Monday, June 29th. B. Riley Financial began coverage on Nutex Health in a report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Weiss Ratings cut Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, July 10th. Finally, Lake Street Capital assumed coverage on shares of Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $243.33.

Nutex Health Trading Down 6.6%

Shares of NASDAQ:NUTX opened at $157.21 on Monday. Nutex Health has a 12-month low of $77.21 and a 12-month high of $204.00. The business has a 50 day moving average of $150.63 and a 200-day moving average of $130.51. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.08 billion, a PE ratio of 12.15 and a beta of 0.21.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.99 by $2.53. The business had revenue of $216.49 million during the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%. As a group, equities research analysts forecast that Nutex Health will post 22.72 earnings per share for the current year.

Institutional Investors Weigh In On Nutex Health

Several hedge funds have recently added to or reduced their stakes in the business. Deutsche Bank AG increased its holdings in Nutex Health by 3.9% in the fourth quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after purchasing an additional 98 shares during the period. Russell Investments Group Ltd. boosted its stake in shares of Nutex Health by 1.4% in the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock valued at $1,433,000 after purchasing an additional 116 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in Nutex Health by 3.7% in the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after buying an additional 200 shares during the period. Islay Capital Management LLC acquired a new stake in Nutex Health during the 4th quarter worth about $34,000. Finally, First Trust Advisors LP boosted its position in shares of Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock valued at $1,887,000 after purchasing an additional 272 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.